These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9286051)

  • 1. Nasal immunization with group B streptococci can induce high levels of specific IgA antibodies in cervicovaginal secretions of mice.
    Hordnes K; Tynning T; Brown TA; Haneberg B; Jonsson R
    Vaccine; 1997 Aug; 15(11):1244-51. PubMed ID: 9286051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic and mucosal antibody responses to group B streptococci following immunization of the colonic-rectal mucosa.
    Hordnes K; Digranes A; Haugen IL; Helland DE; Ulstein M; Jonsson R; Haneberg B
    J Reprod Immunol; 1995 Mar; 28(3):247-62. PubMed ID: 7473434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic and mucosal immune responses in mice after mucosal immunization with group B streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate vaccine.
    Shen X; Lagergård T; Yang Y; Lindblad M; Fredriksson M; Holmgren J
    Infect Immun; 2000 Oct; 68(10):5749-55. PubMed ID: 10992481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle.
    Kozlowski PA; Williams SB; Lynch RM; Flanigan TP; Patterson RR; Cu-Uvin S; Neutra MR
    J Immunol; 2002 Jul; 169(1):566-74. PubMed ID: 12077289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and preclinical evaluation of experimental group B streptococcus type III polysaccharide-cholera toxin B subunit conjugate vaccine for intranasal immunization.
    Shen X; Lagergård T; Yang Y; Lindblad M; Fredriksson M; Holmgren J
    Vaccine; 2000 Nov; 19(7-8):850-61. PubMed ID: 11115709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colonization in the rectum and uterine cervix with group B streptococci may induce specific antibody responses in cervical secretions of pregnant women.
    Hordnes K; Tynning T; Kvam AI; Jonsson R; Haneberg B
    Infect Immun; 1996 May; 64(5):1643-52. PubMed ID: 8613373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical secretions in pregnant women colonized rectally with group B streptococci have high levels of antibodies to serotype III polysaccharide capsular antigen and protein R.
    Hordnes K; Tynning T; Kvam AI; Bevanger L; Brown TA; Jonsson R; Haneberg B
    Scand J Immunol; 1998 Feb; 47(2):179-88. PubMed ID: 9496695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal immunization with GBS surface protein Sip and ScpB induces specific mucosal and systemic immune responses in mice.
    Xue G; Yu L; Li S; Shen X
    FEMS Immunol Med Microbiol; 2010 Mar; 58(2):202-10. PubMed ID: 19912341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pre-existing immunity for systemic and mucosal immune responses to intranasal immunization with group B Streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate.
    Shen X; Lagergård T; Yang Y; Lindblad M; Fredriksson M; Wallerström G; Holmgren J
    Vaccine; 2001 May; 19(25-26):3360-8. PubMed ID: 11348699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit.
    Wu HY; Russell MW
    Infect Immun; 1993 Jan; 61(1):314-22. PubMed ID: 8418053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal administration of recombinant Neisseria gonorrhoeae transferrin binding proteins A and B conjugated to the cholera toxin B subunit induces systemic and vaginal antibodies in mice.
    Price GA; Russell MW; Cornelissen CN
    Infect Immun; 2005 Jul; 73(7):3945-53. PubMed ID: 15972481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant.
    Isaka M; Yasuda Y; Taniguchi T; Kozuka S; Matano K; Maeyama J; Morokuma K; Ohkuma K; Goto N; Tochikubo K
    Vaccine; 2003 Mar; 21(11-12):1165-73. PubMed ID: 12559794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal immunization with lipoteichoic acid and cholera toxin evokes specific pharyngeal IgA and systemic IgG responses and inhibits streptococcal adherence to pharyngeal epithelial cells in mice.
    Yokoyama Y; Harabuchi Y
    Int J Pediatr Otorhinolaryngol; 2002 May; 63(3):235-41. PubMed ID: 11997159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Group B Streptococcus capsular polysaccharide-cholera toxin B subunit conjugate vaccines prepared by different methods for intranasal immunization.
    Shen X; Lagergård T; Yang Y; Lindblad M; Fredriksson M; Holmgren J
    Infect Immun; 2001 Jan; 69(1):297-306. PubMed ID: 11119518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A nasal whole-cell pertussis vaccine can induce strong systemic and mucosal antibody responses which are not enhanced by cholera toxin.
    Berstad AK; Holst J; Møgster B; Haugen IL; Haneberg B
    Vaccine; 1997; 15(12-13):1473-8. PubMed ID: 9302763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific-antibody-secreting cells in the rectums and genital tracts of nonhuman primates following vaccination.
    Eriksson K; Quiding-Järbrink M; Osek J; Möller A; Björk S; Holmgren J; Czerkinsky C
    Infect Immun; 1998 Dec; 66(12):5889-96. PubMed ID: 9826370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of mucosal and systemic immune responses by intranasal immunization using recombinant cholera toxin B subunit as an adjuvant.
    Wu HY; Russell MW
    Vaccine; 1998; 16(2-3):286-92. PubMed ID: 9607044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal immunization of mice with group B streptococcal protein rib and cholera toxin B subunit confers protection against lethal infection.
    Larsson C; Holmgren J; Lindahl G; Bergquist C
    Infect Immun; 2004 Feb; 72(2):1184-7. PubMed ID: 14742572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces.
    Haneberg B; Kendall D; Amerongen HM; Apter FM; Kraehenbuhl JP; Neutra MR
    Infect Immun; 1994 Jan; 62(1):15-23. PubMed ID: 8262621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective efficacy of rotavirus 2/6-virus-like particles combined with CT-E29H, a detoxified cholera toxin adjuvant.
    Siadat-Pajouh M; Cai L
    Viral Immunol; 2001; 14(1):31-47. PubMed ID: 11270595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.